Table 1 Patient’s laboratory parameters
Parameter | 2 days before 2nd vaccination | 12 days after 2nd vaccination | 5 days later on prednisolone | Normal range |
|---|---|---|---|---|
Blood results | ||||
CRP (mg/dl) | 2.09 | 8.69 | < 0.50 | |
Creatinine (mg/dl) | 0.82 | 0.97 | 1.43 | 0.70–1.20 |
Albumin (g/dl) | 3.5 | 3.5 | 3.1 | 3.5–5.2 |
Total bilirubin (mg/dl) | 1.0 | 1.4 | 0.7 | < 1.4 |
Direct bilirubin /mg/dl) | 0.8 | 0.4 | < 0.3 | |
ASAT (U/l) | 47 | 36 | 51 | < 40 |
ALAT (U/l) | 38 | 25 | 37 | < 50 |
GGT (U/l) | 31 | 44 | 69 | < 50 |
LDH (U/l) | 205 | 211 | 223 | < 248 |
CK (U/l) | 85 | 108 | < 190 | |
Lactate (mg/dl) | 16.3 | 4.5–20.0 | ||
ESR (mm/h) | 42 | 19 | < 20 | |
PCT (ng/ml) | 0.29 | < 0.50 | ||
IL-6 (pg/ml) | 104.0 | 26.6 | < 7.0 | |
Leucocytes (/nl) | 4.57 | 5.87 | 6.01 | 3.92–9.81 |
Haemoglobin (g/dl) | 11.6 | 11.3 | 10.1 | 13.5–17.5 |
Platelets (/nl) | 141 | 114 | 133 | 146–328 |
INR | 1.19 | 1.23 | 1.26 | 0.85–1.27 |
IgG (mg/dl) | 1567 | 1549 | 1364 | 700–1600 |
C3c (mg/dl) | 87 | 90–180 | ||
C4 (mg/dl) | 16.1 | 10.0–40.0 | ||
ANA | 1:80 | < 1:80 | ||
c-ANCA (IFT) | Negative | Negative | ||
p-ANCA (IFT) | Negative | Negative | ||
c-ANCA (PR3) EILSA | Negative | Negative | ||
p-ANCA (MPO) ELISA | Negative | Negative | ||
Urine results | ||||
Leukocytes (/µl) | 350 | 447 | < 10 | |
Erythrocytes (/µl) | 11 | 30 | < 5 | |
Stool results | ||||
Calprotectin (µg/g) | 115 | < 50 | ||
EDN (ng/ml) | 802 | < 1700 | ||
iFOBT | Positive | Negative | ||
Stool pathogens | Negative | |||
Virology | ||||
CMV-DNA | Negative | |||
EBV-DNA | Negative | |||
HSV-1 IgG | positive 17.1 index | |||
HSV-2 IgG | Negative | |||
HHV-6 IgG | Negative | |||
HHV-6 IgM | Negative | |||
VZV IgG | Positive 2727 mE/ml | |||
VZV IgM | Negative | |||
Parvovirus B19 IgG | Positive 10 index | |||
Parvovirus B19 IgM | Negative | |||
Microbiology | ||||
Treponema pallidum screening | Negative | |||
Mycoplasma pneumoniae IgG | Negative | |||
Mycoplasma pneumoniae IgM | Negative | |||